Leustatin Konzentrat zur Herstellung einer Infusionslösung
Country: Switzerland
Language: German
Source: Swissmedic (Swiss Agency for Therapeutic Products)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
cladribinum
Available from:
Atnahs Pharma Switzerland AG
ATC code:
L01BB04
INN (International Name):
cladribinum
Pharmaceutical form:
Konzentrat zur Herstellung einer Infusionslösung
Composition:
cladribinum 10 mg, natrii chloridum, acidum phosphoricum aut dinatrii phosphas heptahydricus, aqua ad iniectabile q.s. ad solutionem pro 10 ml corresp. natrium 38.2 mg.
Class:
A
Therapeutic group:
Synthetika
Therapeutic area:
Haarzellen-Leukämie
Authorization status:
zugelassen
Authorization date:
1998-09-21
